Immunarray vs Nucleix
Immunarray vs Nucleix, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunarray is on 39/100 and Nucleix on 56/100.
Where each one leads
Immunarray
Leads on none of the measures we hold for both companies.
Nucleix
- our overall score: 56/100 against 39/100
- domain rating: 38/100 against 18/100
- funding raised: $102M against $10.0M
At a glance
| Measure | Immunarray | Nucleix |
|---|---|---|
| What it is | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. |
| Category | Healthcare, Blood, Diagnostics, Immunology | Healthcare, Lung, Bladder, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2006 | 2008 |
| Headquarters | Richmond, United States | Rehovot, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Immunarray | Nucleix |
|---|---|---|
| Employees | Not published | 74 |
| Headcount growthLast 12 months | Not published | +7.1% |
| Total funding | $10.0M | $102M |
| Latest round | Series A | Funding Round |
| LinkedIn followers | Not published | 7,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunarray | Nucleix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 56/100 |
| Traction | 35/100 | 59/100 |
| Team | 30/100 | 70/100 |
| Community | 13/100 | Not published |
| Search visibility | 5/100 | 36/100 |
| Quality | 45/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (28/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 18/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunarray | Nucleix |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Immunarray | Nucleix |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
Immunarray vs Nucleix: common questions
Which is better, Immunarray or Nucleix?
On our 0-100 score Nucleix rates higher (56/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Immunarray and Nucleix compare on the numbers?
Nucleix leads on our overall score (56/100 against 39/100), domain rating (38/100 against 18/100), funding raised ($102M against $10.0M).
What do real users say about Immunarray and Nucleix?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full Immunarray review and pricing or the Nucleix review and pricing. You can also browse other Immunarray alternatives we track.